Skip to content

Emmaus Life Sciences, Inc.

EMMA · OTCM

CIK 822370fmd_097JPDQVYVKVGQ1TH329NH28HMManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Oct 01, 2009 to Jun 30, 2026, 65 periods

Latest annual · FY2025

Millions
Total revenues
12
Gross profit
12
Operating income
0
Net income
(7)
Free cash flow
(0)

Latest quarter · Q2 FY2026

Millions
Total revenues
6
Gross profit
6
Operating income
4
Net income
1
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2022 to FY2025
-12.2%
Revenue, 5 yearsFY2020 to FY2025
-11.7%
Net income, 5 yearsFY2020 to FY2025
n/m

Emmaus Life Sciences, Inc. (EMMA) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Revenue$12.5 million$16.7 million-25.2%10-K 2026-03-31 · proof
Gross profit$11.6 million$15.5 million-25%10-K 2026-03-31 · proof
Operating income$231,000-$1.9 million10-K 2026-03-31 · proof
Net income-$7.5 million-$6.5 million10-K 2026-03-31 · proof
Cash from operating activities-$11,000-$2.3 million10-K 2026-03-31 · proof
Free cash flow-$12,000-$2.3 million10-K 2026-03-31 · proof
Total assets$21.4 million$23.6 million-9.2%10-K 2026-03-31 · proof
Total liabilities$85 million$80.1 million+6.2%10-K 2026-03-31 · proof
Cash and cash equivalents$2.1 million$1.4 million+53.1%10-K 2026-03-31 · proof
What was Emmaus Life Sciences, Inc. (EMMA)'s revenue in fiscal 2025?
Emmaus Life Sciences, Inc. (EMMA) reported revenue of $12.5 million for fiscal 2025 (the year ended Dec 31, 2025), against $16.7 million the year before (-25.2%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What was Emmaus Life Sciences, Inc. (EMMA)'s gross profit in fiscal 2025?
Emmaus Life Sciences, Inc. (EMMA) reported gross profit of $11.6 million for fiscal 2025 (the year ended Dec 31, 2025), against $15.5 million the year before (-25%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What was Emmaus Life Sciences, Inc. (EMMA)'s operating income in fiscal 2025?
Emmaus Life Sciences, Inc. (EMMA) reported operating income of $231,000 for fiscal 2025 (the year ended Dec 31, 2025), against -$1.9 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What was Emmaus Life Sciences, Inc. (EMMA)'s net income in fiscal 2025?
Emmaus Life Sciences, Inc. (EMMA) reported net income of -$7.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$6.5 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What was Emmaus Life Sciences, Inc. (EMMA)'s cash from operating activities in fiscal 2025?
Emmaus Life Sciences, Inc. (EMMA) reported cash from operating activities of -$11,000 for fiscal 2025 (the year ended Dec 31, 2025), against -$2.3 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What was Emmaus Life Sciences, Inc. (EMMA)'s free cash flow in fiscal 2025?
Emmaus Life Sciences, Inc. (EMMA) reported free cash flow of -$12,000 for fiscal 2025 (the year ended Dec 31, 2025), against -$2.3 million the year before. Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What are Emmaus Life Sciences, Inc. (EMMA)'s total assets?
As of Dec 31, 2025, Emmaus Life Sciences, Inc. (EMMA) reported total assets of $21.4 million, against $23.6 million a year earlier (-9.2%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What are Emmaus Life Sciences, Inc. (EMMA)'s total liabilities?
As of Dec 31, 2025, Emmaus Life Sciences, Inc. (EMMA) reported total liabilities of $85 million, against $80.1 million a year earlier (+6.2%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC
What are Emmaus Life Sciences, Inc. (EMMA)'s cash and cash equivalents?
As of Dec 31, 2025, Emmaus Life Sciences, Inc. (EMMA) reported cash and cash equivalents of $2.1 million, against $1.4 million a year earlier (+53.1%). Source: the 10-K filed with the SEC on Mar 31, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:EMMA&period_type=annual&limit=5"

Information only, not investment advice.